Suchergebnisse - "Jouve, Thomas"

PubPharm (9)

1

Imlifidase therapy : exploring its clinical uses

enthalten in: Expert opinion on pharmacotherapy | 2023

von Rostaing, L. | Noble, J. | Malvezzi, P. | +1

2

Improving access to kidney transplantation for highly sensitized patients : What place for IL-6 pathway blockade in desensitization protocols?

enthalten in: Nephrologie & therapeutique | 2022

von Weinhard, J. | Noble, J. | Jouve, T. | +2

3

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation : A Literature Review

enthalten in: Frontiers in immunology | 2022

von Cabezas, L. | Jouve, T. | Malvezzi, P. | +4

4

Treatment of antibody-mediated rejection with double-filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation

enthalten in: Journal of clinical apheresis | 2021

von Naciri Bennani, H. | Daligault, M. | Noble, J. | +12

5

The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation) : Impact of the Concentration-Dose Ratio on Death-censored Graft Survival

enthalten in: Transplantation | 2020

von Jouve, T. | Fonrose, X. | Noble, J. | +5

CommentIn: Transpl Int. 2020 Jun;33(6):689-691. - PMID 32163653

6

Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant Patients

enthalten in: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation | 2019

von Villemaire, M. | Jouve, T. | Bourdin, A. | +7

7

Desensitization in the Setting of HLA-Incompatible Kidney Transplant

enthalten in: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation | 2018

von Malvezzi, P. | Jouve, T. | Noble, J. | +1

8

Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection : Predictive Models

enthalten in: Blood purification | 2018

von Jouve, T. | Marlu, R. | Malvezzi, P. | +5

9

Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies

enthalten in: Transplant international : official journal of the European Society for Organ Transplantation | 2014

von Croze, L. | Tetaz, R. | Roustit, M. | +8

1
[1]